Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 9,066 | 1,498 | 1,817 | 1,028 | 274 |
| Cost of Goods | 378 | 230 | 236 | 222 | 137 |
| Gross Profit | 8,688 | 1,268 | 1,581 | 806 | 137 |
| Operating Expenses | 54,162 | 54,189 | 52,806 | 45,268 | 40,706 |
| Operating Income | -45,096 | -52,691 | -50,989 | -44,240 | -40,432 |
| Interest Expense | 46 | 0 | 0 | 0 | 0 |
| Other Income | 141 | -73 | 134 | 138 | 21 |
| Pre-tax Income | -45,001 | -52,764 | -50,855 | -44,102 | -40,411 |
| Income Tax | N/A | N/A | N/A | -8,995 | -5,022 |
| Net Income Continuous | -45,001 | -52,764 | -42,866 | -35,107 | -35,389 |
| Net Income | $-45,001 | $-52,764 | $-42,866 | $-35,107 | $-35,389 |
| EPS Basic Total Ops | -0.89 | -1.05 | -0.92 | -0.70 | -0.70 |
| EPS Basic Continuous Ops | -0.89 | -1.05 | -0.92 | -0.70 | -0.70 |
| EPS Diluted Total Ops | -0.89 | -1.05 | -0.90 | -0.70 | -0.70 |
| EPS Diluted Continuous Ops | -0.89 | -1.05 | -0.90 | -0.70 | -0.70 |
| EBITDA(a) | $-44,658 | $-52,341 | $-50,664 | $-43,925 | $-40,115 |